The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: A systematic review and meta-analysis

Younossi, 2016, Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes, Hepatology, 64, 73, 10.1002/hep.28431

Chalasani, 2018, The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases, Hepatology, 67, 328, 10.1002/hep.29367

Byrne, 2015, NAFLD: a multisystem disease, J Hepatol, 62, S47, 10.1016/j.jhep.2014.12.012

Browning, 2004, Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity, Hepatology, 40, 1387, 10.1002/hep.20466

Younossi, 2018, Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention, Nat Rev Gastroenterol Hepatol, 15, 11, 10.1038/nrgastro.2017.109

Younossi, 2004, Nonalcoholic fatty liver disease in patients with type 2 diabetes, Clin Gastroenterol Hepatol, 2, 262, 10.1016/S1542-3565(04)00014-X

Hossain, 2009, Independent predictors of fibrosis in patients with nonalcoholic fatty liver disease, Clin Gastroenterol Hepatol, 7, 10.1016/j.cgh.2009.06.007

Stepanova, 2013, Predictors of all-cause mortality and liver-related mortality in patients with non-alcoholic fatty liver disease (NAFLD), Dig Dis Sci, 58, 3017, 10.1007/s10620-013-2743-5

Fracanzani, 2008, Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: a role for insulin resistance and diabetes, Hepatology, 48, 792, 10.1002/hep.22429

Mofrad, 2003, Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values, Hepatology, 37, 1286, 10.1053/jhep.2003.50229

Portillo-Sanchez, 2015, High prevalence of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus and normal plasma aminotransferase levels, J Clin Endocrinol Metab, 100, 2231, 10.1210/jc.2015-1966

Lonardo, 2016, Fatty liver is associated with an increased risk of diabetes and cardiovascular disease – evidence from three different disease models: NAFLD, HCV and HIV, World J Gastroenterol, 22, 9674, 10.3748/wjg.v22.i44.9674

Birkenfeld, 2014, Nonalcoholic fatty liver disease, hepatic insulin resistance, and type 2 diabetes, Hepatology, 59, 713, 10.1002/hep.26672

Baffy, 2012, Hepatocellular carcinoma in non-alcoholic fatty liver disease: an emerging menace, J Hepatol, 56, 1384, 10.1016/j.jhep.2011.10.027

Rafiq, 2009, Long-term follow-up of patients with nonalcoholic fatty liver, Clin Gastroenterol Hepatol, 7, 234, 10.1016/j.cgh.2008.11.005

Stepanova, 2010, Components of metabolic syndrome are independent predictors of mortality in patients with chronic liver disease: a population-based study, Gut, 59, 1410, 10.1136/gut.2010.213553

Estes, 2018, Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease, Hepatology, 67, 123, 10.1002/hep.29466

Younossi, 2011, Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008, Clin Gastroenterol Hepatol, 9, 10.1016/j.cgh.2011.03.020

Younossi, 2015, Association of nonalcoholic fatty liver disease (NAFLD) with hepatocellular carcinoma (HCC) in the United States from 2004 to 2009, Hepatology, 62, 1723, 10.1002/hep.28123

Cholankeril, 2017, Liver transplantation for nonalcoholic steatohepatitis in the US: temporal trends and outcomes, Dig Dis Sci, 62, 2915, 10.1007/s10620-017-4684-x

Younossi, 2018, Non-alcoholic steatohepatitis is the fastest growing cause of hepatocellular carcinoma in liver transplant candidates, Clin Gastroenterol Hepatol

Blais, 2015, Nonalcoholic fatty liver disease is underrecognized in the primary care setting, Am J Gastroenterol, 110, 10, 10.1038/ajg.2014.134

Sutton, 2000, Modelling publication bias in meta-analysis: a review, Stat Methods Med Res, 9, 421, 10.1177/096228020000900503

Lipsey, 2001, The way in which intervention studies have “personality” and why it is important to meta-analysis, Eval Health Prof, 24, 236

Veroniki, 2016, Methods to estimate the between-study variance and its uncertainty in meta-analysis, Res Synth Methods, 7, 55, 10.1002/jrsm.1164

Berkey, 1995, A random-effects regression model for meta-analysis, Stat Med, 14, 395, 10.1002/sim.4780140406

Greenland, 2001, On the bias produced by quality scores in meta-analysis, and a hierarchical view of proposed solutions, Biostatistics, 2, 463, 10.1093/biostatistics/2.4.463

Knapp, 2003, Improved tests for a random effects meta-regression with a single covariate, Stat Med, 22, 2693, 10.1002/sim.1482

Hommel, 1988, A stagewise rejective multiple test procedure based on a modified Bonferroni test, Biometrika, 75, 383, 10.1093/biomet/75.2.383

Country Comparison: Population. Central Intelligence Agency (CIA). Central Intelligence Agency (CIA) 2018. https://www.cia.gov/library/publications/the-world-factbook/rankorder/2119rank.html (accessed February 4, 2019).

Buehler, 1957, Confidence intervals for the product of two binomial parameters, J Am Stat Assoc, 52, 482, 10.1080/01621459.1957.10501404

Begg, 1994, Operating characteristics of a rank correlation test for publication bias, Biometrics, 50, 1088, 10.2307/2533446

Egger, 1997, Bias in meta-analysis detected by a simple, graphical test, BMJ, 315, 629, 10.1136/bmj.315.7109.629

Viechtbauer, 2010, Conducting meta-analyses in R with the metafor package, J Statistical Software, Articles, 36, 1

Health Organization W. Global report on diabetes 2016.

Dai, 2017, Prevalence of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus: a meta-analysis, Medicine, 96, 10.1097/MD.0000000000008179

Mahady, 2018, Burden of non-alcoholic fatty liver disease in Australia, J Gastroenterol Hepatol, 33, 1, 10.1111/jgh.14270

Kalra, 2013, Study of prevalence of nonalcoholic fatty liver disease (NAFLD) in type 2 diabetes patients in India (SPRINT), J Assoc Physicians India, 61, 448

Targher, 2015, A perspective on metabolic syndrome and nonalcoholic fatty liver disease, Metab Syndr Relat Disord, 13, 235, 10.1089/met.2015.1502

Firneisz, 2014, Non-alcoholic fatty liver disease and type 2 diabetes mellitus: the liver disease of our age?, World J Gastroenterol, 20, 9072

Leite, 2009, Prevalence and associated factors of non-alcoholic fatty liver disease in patients with type-2 diabetes mellitus, Liver Int, 29, 113, 10.1111/j.1478-3231.2008.01718.x

Bril, 2017, Management of nonalcoholic fatty liver disease in patients with type 2 diabetes: a call to action, Diabetes Care, 40, 419, 10.2337/dc16-1787

Hazlehurst, 2016, Non-alcoholic fatty liver disease and diabetes, Metabolism, 65, 1096, 10.1016/j.metabol.2016.01.001

CDC. Center for Disease Control and Prevention – Viral hepatitis – Surveillance for viral hepatitis 2014;2018.

Burney, 2015, Global and regional trends in COPD mortality, 1990–2010, Eur Respir J, 45, 1239, 10.1183/09031936.00142414

CDC - Data and Statistics - Chronic Obstructive Pulmonary Disease (COPD) 2018. https://www.cdc.gov/copd/data.html (accessed November 26, 2018).

Cavaillès, 2013, Comorbidities of COPD, Eur Respir Rev, 22, 454, 10.1183/09059180.00008612

CDC. Center for Disease Control and Prevention – Chronic obstructive pulmonary disease – Data and statistics 2014;2018.

Dulai, 2017, Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: systematic review and meta-analysis, Hepatology, 65, 1557, 10.1002/hep.29085

Younossi, 2011, Pathologic criteria for nonalcoholic steatohepatitis: interprotocol agreement and ability to predict liver-related mortality, Hepatology, 53, 1874, 10.1002/hep.24268

Stepanova, 2017, Patients with diabetes and chronic liver disease are at increased risk for overall mortality: a population study from the United States, Clin Diabetes, 35, 79, 10.2337/cd16-0018

Golabi, 2016, Current complications and challenges in nonalcoholic steatohepatitis screening and diagnosis, Expert Rev Gastroenterol Hepatol, 10, 63, 10.1586/17474124.2016.1099433

Anderson, 2015, The prevalence of non-alcoholic fatty liver disease in children and adolescents: a systematic review and meta-analysis, PLoS ONE, 10, 10.1371/journal.pone.0140908

Reade, 2008, Bench-to-bedside review: avoiding pitfalls in critical care meta-analysis–funnel plots, risk estimates, types of heterogeneity, baseline risk and the ecologic fallacy, Crit Care, 12, 220, 10.1186/cc6941

Schwartz, 1994, The fallacy of the ecological fallacy: the potential misuse of a concept and the consequences, Am J Public Health, 84, 819, 10.2105/AJPH.84.5.819